Sino Biopharmaceutical (OTCMKTS:SBMFF – Get Free Report)’s stock price gapped up before the market opened on Monday . The stock had previously closed at $0.6509, but opened at $0.7384. Sino Biopharmaceutical shares last traded at $0.7384, with a volume of 300 shares trading hands.
Sino Biopharmaceutical Stock Performance
The business has a fifty day moving average of $0.64 and a 200-day moving average of $0.71.
Sino Biopharmaceutical Company Profile
Sino Biopharmaceutical Limited (OTCMKTS: SBMFF) is a Hong Kong–incorporated investment holding company principally engaged in the pharmaceutical sector. Founded in 2000 and listed on the Hong Kong Stock Exchange in 2006, the company has developed an integrated business model that spans research and development, manufacturing and commercialization of healthcare products. Through its subsidiaries, Sino Biopharmaceutical focuses on enhancing China’s domestic pharmaceutical infrastructure while expanding its footprint across key therapeutic areas.
The company’s product portfolio is organized into three core segments: infusion solutions, small-molecule synthetic pharmaceuticals and innovative biologics.
Recommended Stories
- Five stocks we like better than Sino Biopharmaceutical
- Dutch Bros Sell-Off Creates a Growth Opportunity
- NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat
- Is Abercrombie & Fitch’s Hot Streak Just Getting Started?
- Medtronic’s Stars Are Aligning for a Price Recovery
Receive News & Ratings for Sino Biopharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sino Biopharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
